The Platform
RENOVÓ
Biologics — the exosome, Wharton's jelly and conditioned media platform
Three biological categories. Each serving a distinct and irreplaceable role. This is what each one is, what it does, and how they are used together.
I
Vesicle-Mediated Signalling
Exosomes
Membrane-bound extracellular vesicles produced from two distinct human umbilical cord starting materials — Wharton's jelly, for EXO-10, EXO-30 and EXO-50; and umbilical cord blood plasma, endothelial stem cell derived, for EXO-90 and EXO-180. Exosomes carry protected biological information — growth factors, signalling proteins, and intercellular communication — in a form the body recognises as its own. They carry the same class of signal the body produces in abundance early in life and produces less of with age.
EXO-10
Consumer & Clinical
Wharton's Jelly · Topical
Concentration12.23 ±1.73B
Composition20 Amino Acids with WJ Exosomes
Volume5mL
FormatLyophilised
ReconstitutionCopper Peptide Solution
The entry point to the Wharton's jelly line. Configured for focal topical application — smaller treatment areas, introductory protocols, and single-region skin and hair work where the full EXO-30 concentration is not indicated.
View in Catalogue
EXO-30
Consumer & Clinical
Wharton's Jelly · Topical
Concentration32.5 ±1.73B
Volume5mL
FormatLyophilised
ReconstitutionCopper Peptide Solution
Wharton's jelly–derived exosomes with collagen peptides. The surface-oriented formulation — configured specifically for skin rejuvenation, hair restoration, and topical tissue repair.
View in Catalogue
EXO-50
Consumer & Clinical
Wharton's Jelly · Topical & Systemic
Concentration52.5 ±1.73B
Volume5mL
FormatLyophilised
ReconstitutionCopper Peptide Solution
The foundational Wharton's jelly systemic formulation — used across regenerative aesthetics and musculoskeletal protocols, for both topical and systemic application.
View in Catalogue
EXO-90
Consumer & Clinical
Endothelial · Systemic
Concentration90B exosomes
Volume1mL
FormatLyophilised
SourceEndothelial SC · Cord Blood Plasma
Umbilical cord blood plasma, endothelial stem cell derived exosomes for systemic administration. Published characterisation of endothelial-derived vesicles reports VEGF, ANG-1 and BDNF among cargo constituents. RENOVÓ states the source and the size distribution.
View in Catalogue
EXO-180
Clinical Only
Endothelial · Advanced Systemic
Concentration180B exosomes
Volume1mL
FormatCryopreserved
SourceEndothelial SC · Cord Blood Plasma
The apex endothelial formulation — umbilical cord blood plasma, endothelial stem cell derived. Cryopreserved for maximum biological integrity. Specified for advanced clinical protocols, and for the full biological environment protocol alongside WJ-300 and CM-2.
Apply for Clinical Access
II
Structural Matrix · Clinical Only
Wharton's Jelly
The connective tissue matrix of the umbilical cord. Rich in hyaluronic acid, collagen, proteoglycans, and the structural proteins that define connective tissue architecture. Wharton's Jelly supplies the components of the extracellular environment — the physical space in which cellular activity occurs. Formulations are distinguished by total tissue content, concentration and format. All formulations are clinical use only.
WJ-75
Clinical Only
Structural · Broad Distribution
Tissue Content75mg
Volume3mL
Concentration25 mg/mL
FormatFrozen
Frozen Wharton's jelly for broad surface distribution. Lower concentration, larger area applications — specified by practitioners for surface-level structural placement in regenerative aesthetic contexts alongside EXO-30 or EXO-50.
Apply for Clinical Access
WJ-95
Clinical Only
Concentrated · Small Joints
Tissue Content95mg
ConcentrationSet at Reconstitution
FormatLyophilised
Lyophilised Wharton's jelly for concentrated placement in smaller joint environments. The primary small joint musculoskeletal formulation — typically paired with EXO-50 for complete structural and signalling support.
Apply for Clinical Access
WJ-150
Clinical Only
High Density · Structural Joints
Tissue Content150mg
Volume1mL
Concentration150 mg/mL
FormatFrozen
Frozen Wharton's jelly at 150 mg/mL for high density targeted placement in structural joint applications. Paired with EXO-180 for advanced systemic signalling into the restored structural environment.
Apply for Clinical Access
WJ-300
Clinical Only
Maximum Volume · Expanded Environments
Tissue Content300mg
Volume2mL
Concentration150 mg/mL
FormatFrozen
The largest volume Wharton's jelly in the series, at the same 150 mg/mL concentration as WJ-150 with double the total tissue content. For expanded joint and tissue environments — the cornerstone of the full biological environment protocol, paired with EXO-90 and CM-1, or EXO-180 for advanced applications.
Apply for Clinical Access
III
Soluble Signal Environment · Clinical Only
Conditioned Media
The soluble secretome — the full spectrum of growth factors, cytokines, and signalling proteins secreted by umbilical cord stem cells. Conditioned media provides immediate ambient factor availability, filling the biological space the moment treatment is delivered. Clinical use only.
CM-1
Clinical Only
Baseline Soluble Signal Environment
Volume1mL
FormatLiquid Frozen
Signal TypeSoluble · Non-vesicular
Baseline conditioned media providing immediate broad soluble signal availability. The ambient factor component of the full biological environment protocol — paired with WJ-300 and EXO-90 for complete structural, sustained, and immediate signalling coverage.
Apply for Clinical Access
CM-2
Clinical Only
Expanded Soluble Signal Environment
Volume2mL
FormatLiquid Frozen
Signal TypeSoluble · Non-vesicular
Expanded conditioned media for larger tissue area exposure and greater soluble signal reach. The longevity protocol component — paired with EXO-180 to produce the most complete systemic regenerative environment available within the RENOVÓ platform.
Apply for Clinical Access
Clinical Optimisation Portfolio
The peptide portfolio sits alongside the platform, not inside it.
RENOVÓ supplies a clinical peptide portfolio to verified clinical partners, as an adjunct to the three biological categories above. The portfolio is not listed publicly. It is disclosed on approval, and ordered by request rather than through online checkout.
Order from the catalogue
This page is the platform. The catalogue is where every biological formulation is listed with availability and pricing.